Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis

SGC Kroeze; C Fritz; D Kaul; O Blanck; KH Kahl; F Roeder; S Siva; JJC Verhoeff; AL Grosu; M Schymalla; M Glatzer; M Szuecs; M Geier; G Skazikis; I Sackerer; F Lohaus; F Eckert; M Guckenberger

Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis

SGC Kroeze, C Fritz, D Kaul, O Blanck, KH Kahl, F Roeder, S Siva, JJC Verhoeff, AL Grosu, M Schymalla, M Glatzer, M Szuecs, M Geier, G Skazikis, I Sackerer, F Lohaus, F Eckert, M Guckenberger

Department of Radiotherapy and Radiation Oncology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	S49-S49
Journal	STRAHLENTHERAPIE UND ONKOLOGIE
Volume	195
Publication status	Published - 2019
Event	25th Annual Meeting of the German-Society-of-Radiation-Oncology (DEGRO) - Munster, GERMANY Duration: 13 Jun 2019 → 16 Jun 2019

Cite this

Kroeze, SGC., Fritz, C., Kaul, D., Blanck, O., Kahl, KH., Roeder, F., Siva, S., Verhoeff, JJC., Grosu, AL., Schymalla, M., Glatzer, M., Szuecs, M., Geier, M., Skazikis, G., Sackerer, I., Lohaus, F., Eckert, F., & Guckenberger, M. (2019). Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. STRAHLENTHERAPIE UND ONKOLOGIE , 195, S49-S49.

Kroeze, SGC ; Fritz, C ; Kaul, D et al. / Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. In: STRAHLENTHERAPIE UND ONKOLOGIE 2019 ; Vol. 195. pp. S49-S49.

@article{ca61bf6eb42a4a53b8bfd98ef13e9725,

title = "Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis",

author = "SGC Kroeze and C Fritz and D Kaul and O Blanck and KH Kahl and F Roeder and S Siva and JJC Verhoeff and AL Grosu and M Schymalla and M Glatzer and M Szuecs and M Geier and G Skazikis and I Sackerer and F Lohaus and F Eckert and M Guckenberger",

year = "2019",

language = "English",

volume = "195",

pages = "S49--S49",

journal = "STRAHLENTHERAPIE UND ONKOLOGIE ",

issn = "0179-7158",

publisher = "Springer Nature",

note = "25th Annual Meeting of the German-Society-of-Radiation-Oncology (DEGRO) ; Conference date: 13-06-2019 Through 16-06-2019",

}

Kroeze, SGC, Fritz, C, Kaul, D, Blanck, O, Kahl, KH, Roeder, F, Siva, S, Verhoeff, JJC, Grosu, AL, Schymalla, M, Glatzer, M, Szuecs, M, Geier, M, Skazikis, G, Sackerer, I, Lohaus, F, Eckert, F & Guckenberger, M 2019, 'Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis', STRAHLENTHERAPIE UND ONKOLOGIE , vol. 195, pp. S49-S49.

Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. / Kroeze, SGC; Fritz, C; Kaul, D et al.
In: STRAHLENTHERAPIE UND ONKOLOGIE , Vol. 195, 2019, p. S49-S49.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis

AU - Kroeze, SGC

AU - Fritz, C

AU - Kaul, D

AU - Blanck, O

AU - Kahl, KH

AU - Roeder, F

AU - Siva, S

AU - Verhoeff, JJC

AU - Grosu, AL

AU - Schymalla, M

AU - Glatzer, M

AU - Szuecs, M

AU - Geier, M

AU - Skazikis, G

AU - Sackerer, I

AU - Lohaus, F

AU - Eckert, F

AU - Guckenberger, M

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 0179-7158

VL - 195

SP - S49-S49

JO - STRAHLENTHERAPIE UND ONKOLOGIE

JF - STRAHLENTHERAPIE UND ONKOLOGIE

T2 - 25th Annual Meeting of the German-Society-of-Radiation-Oncology (DEGRO)

Y2 - 13 June 2019 through 16 June 2019

ER -

Kroeze SGC, Fritz C, Kaul D, Blanck O, Kahl KH, Roeder F et al. Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. STRAHLENTHERAPIE UND ONKOLOGIE . 2019;195:S49-S49.